Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-resistant, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03569280
What this trial is testing

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Who this might be right for
Castration-Resistant Prostate Cancer
Kangpu Biopharmaceuticals, Ltd. 16
Not applicableStudy completedNCT04962880
What this trial is testing

HRR Prevalence in LatAm PROSPECT Study

Who this might be right for
Castration-resistant Prostate Cancer
AstraZeneca 388
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747
What this trial is testing

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
M.D. Anderson Cancer Center 173
Large-scale testing (Phase 3)Looking for participantsNCT06470243
What this trial is testing

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
SWOG Cancer Research Network 528
Testing effectiveness (Phase 2)Ended earlyNCT04616547
What this trial is testing

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT02095717
What this trial is testing

Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)

Who this might be right for
Prostate Cancer Metastatic Castration Resistant
Centre Jean Perrin 50
Not applicableAvailableNCT05650476
What this trial is testing

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer
Early research (Phase 1)Study completedNCT03276572
What this trial is testing

Phase I Trial of 225Ac-J591 in Patients With mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 32
Post-approval studies (Phase 4)Looking for participantsNCT06099093
What this trial is testing

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Carcinoma
Brigham and Women's Hospital 30
Early research (Phase 1)Study completedNCT03822871
What this trial is testing

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 17
Not applicableStudy completedNCT02981797
What this trial is testing

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Who this might be right for
Prostate CancerProstate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableUnknownNCT02362620
What this trial is testing

PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.

Who this might be right for
Advanced Prostate CancerCabazitaxelDocetaxel
Centro Nacional de Investigaciones Oncologicas CARLOS III 402
Not applicableStudy completedNCT06809426
What this trial is testing

Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer

Who this might be right for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Affiliated Hospital of Jiangnan University 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07104643
What this trial is testing

Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

Who this might be right for
mCRPC
TYK Medicines, Inc 48
Testing effectiveness (Phase 2)Looking for participantsNCT05766371
What this trial is testing

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer+1 more
University of California, San Francisco 48
Not applicableStudy completedNCT03328364
What this trial is testing

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma a/s 211
Very early researchStudy completedNCT05725070
What this trial is testing

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
ARTBIO Inc. 3
Testing effectiveness (Phase 2)Study completedNCT04869488
What this trial is testing

A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 93
Testing effectiveness (Phase 2)UnknownNCT05262608
What this trial is testing

The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation

Who this might be right for
Prostate CancerProstate CarcinomaMetastatic Castration-resistant Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Next Page